Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults – A randomized controlled trial
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Introduction: The polyphenol resveratrol has been suggested to exert beneficial effects on memory and the aging hippocampus due to calorie‐restriction mimicking effects. However, the evidence based on human interventional studies is scarce. We therefore aimed to determine the effects of resveratrol on memory performance, and to identify potential underlying mechanisms using a broad array of blood‐based biomarkers as well as hippocampus connectivity and microstructure assessed with ultra‐high field magnetic resonance imaging (UHF‐MRI). Methods: In this double‐blind, randomized controlled trial, 60 elderly participants (60–79 years) with a wide body‐mass index (BMI) range of 21–37 kg/m2 were randomized to receive either resveratrol (200mg/day) or placebo for 26 weeks (registered at ClinicalTrials.gov: NCT02621554). Baseline and follow‐up assessments included the California Verbal Learning Task (CVLT, main outcome), the ModBent task, anthropometry, markers of glucose and lipid metabolism, inflammation and neurotrophins derived from fasting blood, multimodal neuroimaging at 3 and 7T, and questionnaires to assess confounding factors. Results: Multivariate repeated‐measures ANOVA did not detect significant time by group effects for CVLT performance. There was a trend for preserved pattern recognition memory after resveratrol, while performance decreased in the placebo group (n.s., p=0.07). Further exploratory analyses showed increases in both groups over time in body fat, cholesterol, fasting glucose, interleukin 6, high sensitive C‐reactive protein, tumor necrosis factor alpha and in mean diffusivity of the subiculum and presubiculum, as well as decreases in physical activity, brain‐derived neurotrophic factor and insulin‐like growth factor 1at follow‐up, which were partly more pronounced after resveratrol. Discussion: This interventional study failed to show significant improvements in verbal memory after 6 months of resveratrol in healthy elderly with a wide BMI range. A non‐significant trend emerged for positive effects on pattern recognition memory, while possible confounding effects of unfavorable changes in lifestyle behavior, neurotrophins and inflammatory markers occurred. Our findings also indicate the feasibility to detect (un)healthy aging‐related changes in measures of hippocampus microstructure after 6 months using 7T diffusion MRI. More studies incorporating a longer duration and larger sample size are needed to determine if resveratrol enhances memory performance in healthy older adults. HIGHLIGHTSIn this randomized clinical trial, 6 months resveratrol supplementation showed no significant effects on verbal memory compared to placebo.Unfavorable changes in lifestyle factors at follow‐up might have introduced confounding.Secondary analyses showed a trend towards preserved pattern recognition.We used multimodal ultra high field MRI to detect subtle changes in microstructure of hippocampus subfields.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615
Exercise training increases size of hippocampus and improves memory
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015950108 · Cited by 4,855
A reproducible evaluation of ANTs similarity metric performance in brain image registration
Avants, B. B., Tustison, N. J., Song, G., Cook, P. A., Klein, A., & Gee, J. C. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.025 · Cited by 4,796
Methods to detect, characterize, and remove motion artifact in resting state fMRI
Power, J. D., Mitra, A., Laumann, T. O., Snyder, A. Z., Schlaggar, B. L., & Petersen, S. E. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.048 · Cited by 3,748 · cited 1×
“In addition, as motion is an important confounder in rs-fMRI we performed a sensitivity analysis following the scrubbing approach described in (Power et al., 2014).”
MethodPermutation inference for the general linear model
Winkler, A. M., Ridgway, G. R., Webster, M. A., Smith, S. M., & Nichols, T. E. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.01.060 · Cited by 3,563 · cited 20×
“, 2017) including 255 participants of four studies (Witte et al., 2014; Wightman et al., 2015; Evans et al., 2017; Kobe et al., 2017) concluded that resveratrol has no significant impact on cognitive performance.”
BackgroundMethodResultInfluentialJessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Chételat, G., Dubois, B., Dufouil, C., Ellis, K. A., van der Flier, W. M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.001 · Cited by 3,014
Within-subject template estimation for unbiased longitudinal image analysis
Reuter, M., Schmansky, N. J., Rosas, H. D., & Fischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.084 · Cited by 2,356
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus
Pereira, A. C., Huddleston, D. E., Brickman, A. M., Sosunov, A. A., Hen, R., McKhann, G. M., Sloan, R., Gage, F. H., Brown, T. R., & Small, S. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611721104 · Cited by 1,353 · cited 2×
“Notably, so far only few longitudinal studies in healthy elderly were able to show plastic changes in either regional hippocampus blood volume (Pereira et al., 2007; Brickman et al., 2014) or functional connectivity and volume (Erickson et al.”
BackgroundTimmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320 · cited 1×
“More specifically, “at risk” populations with overweight, obesity or type II diabetes did benefit from resveratrol intake (Timmers et al., 2011; Bhatt et al., 2012; Witte et al., 2014), while those with normal weight did not (Yoshino et al.”
BackgroundThe Effect of Social Desirability and Social Approval on Self-Reports of Physical Activity
Adams, S. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi054 · Cited by 1,160
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051 · cited 1×
“While the biological activity of resveratrol and its metabolites is still incompletely understood, serum measures might be regarded as rather short-term markers of resveratrol intake (see Walle 2011 for further discussions).”
BackgroundInflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · cited 1×
“In sum, all of these factors are known to affect brain structure and function (Mattson et al., 2004; Cherbuin et al., 2012; Wyss-Coray and Rogers, 2012), and could therefore represent additional confounding factors.”
BackgroundBlueberry supplementation improves memory in older adults
Krikorian, R., Shidler, M. D., Nash, T. A., Kalt, W., Vinqvist-Tymchuk, M. R., Shukitt-Hale, B., & Joseph, J. A. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9029332 · Cited by 582 · cited 1×
“Using small- to moderate sample sizes, few randomized controlled trials (RCTs) in older adults reported improved memory performance after supplementary intake of berry juice or formulas with cocoa-flavonol or other polyphenol-containing ingredients (Krikorian et al., 2010; Brickman et al., 2014; Small et al., 2014).”
BackgroundCaloric restriction improves memory in elderly humans
Witte, A. V., Fobker, M., Gellner, R., Knecht, S., & Flöel, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808587106 · Cited by 574
Self-citationFunctional network disruption in the degenerative dementias
Pievani, M., de Haan, W., Wu, T., Seeley, W. W., & Frisoni, G. B. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70158-2 · Cited by 481
The molecular targets of resveratrol
Kulkarni, S. S., & Cantó, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.005 · Cited by 477 · cited 1×
“In vitro as well as in vivo rodent and primate studies provided evidence for antioxidative, anti-inflammatory and calorie-restriction mimicking characteristics of resveratrol (Baur, 2010; Bastianetto et al., 2015; Kulkarni and Canto, 2015).”
BackgroundResveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475 · cited 1×
“More specifically, “at risk” populations with overweight, obesity or type II diabetes did benefit from resveratrol intake (Timmers et al., 2011; Bhatt et al., 2012; Witte et al., 2014), while those with normal weight did not (Yoshino et al.”
BackgroundHigh-Dose Resveratrol Supplementation in Obese Men
Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455 · cited 1×
“, 2014), while those with normal weight did not (Yoshino et al., 2012; Poulsen et al., 2013; Liu et al., 2014).”
BackgroundWitte, A. V., Kerti, L., Margulies, D. S., & Floel, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0385-14.2014 · Cited by 455
Self-citationKennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A., & Haskell, C. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28641 · Cited by 415 · cited 1×
“Two studies led by Kennedy and colleagues suggested that acute doses of 250mg or 500mg resveratrol enhance cerebral blood flow (Kennedy et al., 2010; Wightman et al., 2015).”
BackgroundVascular hippocampal plasticity after aerobic exercise in older adults.
Maass, A., Düzel, S., Goerke, M., Becke, A., Sobieray, U., Neumann, K., Lövden, M., Lindenberger, U., Bäckman, L., Braun-Dullaeus, R., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.114 · Cited by 382
Fellgiebel, A., Wille, P., Müller, M. J., Winterer, G., Scheurich, A., Vucurevic, G., Schmidt, L. G., & Stoeter, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077817 · Cited by 298 · cited 1×
“This has been supported by several studies in beginning Alzheimer’s pathology and memory decline (Fellgiebel et al., 2004; Kantarci et al., 2005; Muller et al., 2005; Muller et al., 2007).”
ResultDWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment
Kantarci, K., Petersen, R. C., Boeve, B. F., Knopman, D. S., Weigand, S. D., O’Brien, P. C., Shiung, M. M., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000153076.46126.e9 · Cited by 251
Weston, P. S. J., Simpson, I. J. A., Ryan, N. S., Ourselin, S., & Fox, N. C. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0132-3 · Cited by 214
Functional implications of hippocampal volume and diffusivity in mild cognitive impairment
Müller, M. J., Greverus, D., Dellani, P. R., Weibrich, C., Wille, P. R., Scheurich, A., Stoeter, P., & Fellgiebel, A. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.029 · Cited by 210 · cited 1×
“This has been supported by several studies in beginning Alzheimer’s pathology and memory decline (Fellgiebel et al., 2004; Kantarci et al., 2005; Muller et al., 2005; Muller et al., 2007).”
ResultDiagnostic utility of hippocampal size and mean diffusivity in amnestic MCI.
Müller, M. J., Greverus, D., Weibrich, C., Dellani, P. R., Scheurich, A., Stoeter, P., & Fellgiebel, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.01.009 · Cited by 140 · cited 1×
“This has been supported by several studies in beginning Alzheimer’s pathology and memory decline (Fellgiebel et al., 2004; Kantarci et al., 2005; Muller et al., 2005; Muller et al., 2007).”
ResultAnton, S. D., Embry, C., Marsiske, M., Lu, X., Doss, H., Leeuwenburgh, C., & Manini, T. M. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.05.015 · Cited by 95
Cited by
Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review
Meng, X., Zhou, J., Zhao, C.-N., Gan, R.-Y., & Li, H.-B. (2020) · Foods · doi:10.3390/foods9030340 · Cited by 387
The effects of plant-based diets on the body and the brain: a systematic review
Medawar, E., Huhn, S., Villringer, A., & Veronica Witte, A. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0552-0 · Cited by 343
Self-citationThe Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases
Jiao, F., & Gong, Z. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6782872 · Cited by 288
Neurogenesis in aging and age-related neurodegenerative diseases
Culig, L., Chu, X., & Bohr, V. A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101636 · Cited by 218
Polyphenols and neuroprotection: therapeutic implications for cognitive decline
Caruso, G., Torrisi, S. A., Mogavero, M. P., Currenti, W., Castellano, S., Godos, J., Ferri, R., Galvano, F., Leggio, G. M., Grosso, G., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108013 · Cited by 140
Metadata
- Authors
- Huhn, S., Beyer, F., Zhang, R., Lampe, L., Grothe, J., Kratzsch, J., Willenberg, A., Breitfeld, J., Kovacs, P., Stumvoll, M., Trampel, R., Bazin, P.-L., Villringer, A., & Witte, A. V.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 174
- Pages
- 177-190
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2791606815
- Cited by
- 94
- References
- 28
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.